162 related articles for article (PubMed ID: 10327996)
1. [Chronic visceral leishmaniasis during chemotherapy for metastatic osteosarcoma].
Marguglio A; Hoyoux C; Dresse MF; Chantraine JM; Thiry A; Gillet P
Arch Pediatr; 1998 Mar; 5(3):285-8. PubMed ID: 10327996
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus.
Torre-Cisneros J; Villanueva JL; Kindelan JM; Jurado R; Sanchez-Guijo P
Clin Infect Dis; 1993 Oct; 17(4):625-7. PubMed ID: 8268341
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of visceral leishmaniasis in children].
Minodier P; Noël G; Blanc P; Uters M; Retornaz K; Garnier JM
Med Trop (Mars); 2007 Feb; 67(1):73-8. PubMed ID: 17506279
[TBL] [Abstract][Full Text] [Related]
4. Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group.
Laguna F; López-Vélez R; Pulido F; Salas A; Torre-Cisneros J; Torres E; Medrano FJ; Sanz J; Picó G; Gómez-Rodrigo J; Pasquau J; Alvar J
AIDS; 1999 Jun; 13(9):1063-9. PubMed ID: 10397536
[TBL] [Abstract][Full Text] [Related]
5. Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?
Kafetzis DA; Velissariou IM; Stabouli S; Mavrikou M; Delis D; Liapi G
Int J Antimicrob Agents; 2005 Jan; 25(1):26-30. PubMed ID: 15620822
[TBL] [Abstract][Full Text] [Related]
6. Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients.
Minodier P; Retornaz K; Horelt A; Garnier JM
Fundam Clin Pharmacol; 2003 Apr; 17(2):183-8. PubMed ID: 12667228
[TBL] [Abstract][Full Text] [Related]
7. Pediatric visceral leishmaniasis in southern France.
Minodier P; Piarroux R; Garnier JM; Unal D; Perrimond H; Dumon H
Pediatr Infect Dis J; 1998 Aug; 17(8):701-4. PubMed ID: 9726344
[TBL] [Abstract][Full Text] [Related]
8. [Mediterranean visceral leishmaniasis in immunocompetent children. Report of two cases relapsed after specific therapy].
Colomba C; Scarlata F; Salsa L; Frasca Polara V; Titone L
Infez Med; 2004 Jun; 12(2):139-43. PubMed ID: 15316302
[TBL] [Abstract][Full Text] [Related]
9. [Visceral leishmaniasis: new drugs].
Minodier P; Robert S; Retornaz K; Garnier JM
Arch Pediatr; 2003 Dec; 10 Suppl 5():550s-556s. PubMed ID: 15022780
[TBL] [Abstract][Full Text] [Related]
10. Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome.
Gangneux JP; Sulahian A; Garin YJ; Farinotti R; Derouin F
Antimicrob Agents Chemother; 1996 May; 40(5):1214-8. PubMed ID: 8723469
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Mediterranean visceral leishmaniasis.
Gradoni L; Bryceson A; Desjeux P
Bull World Health Organ; 1995; 73(2):191-7. PubMed ID: 7743590
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of leishmaniasis in India.
Thakur CP
Indian J Pediatr; 1987; 54(1):7-10. PubMed ID: 3030933
[No Abstract] [Full Text] [Related]
13. Isolation of Leishmania tropica from a patient with visceral leishmaniasis and disseminated cutaneous leishmaniasis, southern Iran.
Alborzi A; Pouladfar GR; Fakhar M; Motazedian MH; Hatam GR; Kadivar MR
Am J Trop Med Hyg; 2008 Sep; 79(3):435-7. PubMed ID: 18784238
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of infantile visceral leishmaniasis].
Minodier P; Faraut-Gambarelli F; Piarroux R; Gire C; Garnier JM; Dumon H
Arch Pediatr; 1999 Jan; 6(1):59-66. PubMed ID: 9974099
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the treatment of visceral leishmaniasis.
Davidson RN; Croft SL
Trans R Soc Trop Med Hyg; 1993; 87(2):130-1, 141. PubMed ID: 8393221
[No Abstract] [Full Text] [Related]
16. Activity of amphotericin B cholesterol dispersion (Amphocil) in experimental visceral leishmaniasis.
Berman JD; Ksionski G; Chapman WL; Waits VB; Hanson WL
Antimicrob Agents Chemother; 1992 Sep; 36(9):1978-80. PubMed ID: 1416890
[TBL] [Abstract][Full Text] [Related]
17. Visceral leishmaniasis during pregnancy treated with meglumine antimoniate.
Utili R; Rambaldi A; Tripodi MF; Andreana A
Infection; 1995; 23(3):182-3. PubMed ID: 7499009
[TBL] [Abstract][Full Text] [Related]
18. Interferon gamma therapy for cutaneous leishmaniasis.
Kürkçüoğlu N; Tandoğdu R
Arch Dermatol; 1990 Jun; 126(6):831-2. PubMed ID: 2111977
[No Abstract] [Full Text] [Related]
19. Visceral leishmaniasis and renal tuberculosis in a patient on maintenance haemodialysis.
Peces R; de la Torre M; Alcázar R
Nephrol Dial Transplant; 1996 Apr; 11(4):707-8. PubMed ID: 8671866
[No Abstract] [Full Text] [Related]
20. Liposomal amphotericin B versus pentavalent antimony salts for visceral Leishmania in children.
Apa H; Devrim İ; Bayram N; Deveci R; Demir-Özek G; Cartı ÖU
Turk J Pediatr; 2013; 55(4):378-83. PubMed ID: 24292030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
